|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 344.10 CHF | +0.94% |
|
+4.30% | +4.84% |
| 07:19am | BGI, Roche roll out diagnostic tests for Alzheimer's in China | RE |
| 01-14 | Roche Pharma CEO on Company's Obesity Assets | MT |
| Capitalization | 294B 368B 316B 274B 511B 33,229B 551B 3,381B 1,330B 15,896B 1,380B 1,352B 58,246B | P/E ratio 2025 * |
19.8x | P/E ratio 2026 * | 18.2x |
|---|---|---|---|---|---|
| Enterprise value | 308B 385B 331B 286B 534B 34,775B 576B 3,538B 1,392B 16,635B 1,445B 1,415B 60,956B | EV / Sales 2025 * |
5x | EV / Sales 2026 * | 4.78x |
| Free-Float |
87.84% | Yield 2025 * |
2.9% | Yield 2026 * | 2.95% |
Last Transcript: Roche Holding AG
| 1 day | +0.94% | ||
| 1 week | +4.30% | ||
| Current month | +4.84% | ||
| 1 month | +8.62% | ||
| 3 months | +18.61% | ||
| 6 months | +34.00% | ||
| Current year | +4.84% |
| 1 week | 336.2 |  | 346 |
| 1 month | 314.7 | | 346 |
| Current year | 323.2 | | 346 |
| 1 year | 231.9 | | 346 |
| 3 years | 212.9 | | 346 |
| 5 years | 212.9 | | 404.2 |
| 10 years | 206.35 | | 404.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 15/03/2023 | |
Alan Hippe
DFI | Director of Finance/CFO | 59 | 06/06/2011 |
Wafaa Mamilli
CTO | Chief Tech/Sci/R&D Officer | 59 | 10/02/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
André Hoffmann
BRD | Director/Board Member | 67 | 01/01/1996 |
Severin Schwan
CHM | Chairman | 59 | 15/03/2023 |
| Director/Board Member | 73 | 03/03/2015 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -.--% | 9.03% | 121 M€ | |
| +1.23% | 8.46% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.94% | +4.30% | +29.90% | +17.96% | 363B | |
| -0.35% | -3.35% | +43.77% | +199.37% | 964B | |
| +1.97% | +5.21% | +50.82% | +26.66% | 515B | |
| +1.04% | -5.04% | +26.27% | +45.04% | 390B | |
| +2.41% | +2.19% | +32.56% | +23.08% | 292B | |
| +2.13% | +4.07% | +27.83% | +37.35% | 272B | |
| +2.63% | +2.15% | +11.32% | +0.43% | 269B | |
| -1.32% | +3.90% | -38.31% | -19.23% | 265B | |
| +0.92% | -4.13% | +22.62% | +21.56% | 175B | |
| +1.53% | -0.57% | +35.87% | +44.77% | 151B | |
| Average | +1.12% | +1.24% | +24.27% | +39.70% | 365.61B | |
| Weighted average by Cap. | +0.88% | +1.51% | +29.76% | +69.07% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 61.57B 77.07B 66.13B 57.3B 107B 6,957B 115B 708B 278B 3,328B 289B 283B 12,195B | 63.12B 79.01B 67.8B 58.74B 110B 7,132B 118B 726B 286B 3,412B 296B 290B 12,502B |
| Net income | 13.08B 16.37B 14.05B 12.17B 22.71B 1,478B 24.48B 150B 59.16B 707B 61.39B 60.13B 2,590B | 14.42B 18.05B 15.49B 13.42B 25.04B 1,629B 26.99B 166B 65.21B 779B 67.68B 66.29B 2,856B |
| Net Debt | 13.68B 17.12B 14.69B 12.73B 23.76B 1,546B 25.61B 157B 61.88B 739B 64.22B 62.89B 2,710B | 7.8B 9.76B 8.37B 7.25B 13.54B 881B 14.59B 89.62B 35.26B 421B 36.59B 35.84B 1,544B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/01/26 | 344.10 CHF | +0.94% | 1,303,682 |
| 13/01/26 | 340.90 CHF | -0.47% | 744,210 |
| 12/01/26 | 342.50 CHF | +0.50% | 1,160,189 |
| 09/01/26 | 340.80 CHF | +0.41% | 1,138,402 |
| 08/01/26 | 339.40 CHF | +0.35% | 1,563,016 |
Delayed Quote Swiss Exchange, January 14, 2026 at 08:30 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ROG Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition